Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2022

MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Partners with Cross River to Launch First Banking-as-a-Service Initiative

Posted on February 16, 2022 by MissionIR

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, announced that it has entered into a licensing agreement with Cross River, a respected technology-driven infrastructure provider that offers embedded financial solutions. GBOX’s partnership with Cross River allows the fintech … Continue reading →

Posted in GreenBox POS. GBOX | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Participate in Fireside Chat at Aegis Virtual Conference

Posted on February 16, 2022 by MissionIR

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that its CEO Doug Drysdale will participate in a fireside chat at the Aegis Virtual Conference. The event will span three days, from … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

Following Successful Sildenafil Animal Study, Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Plans for More Studies in 2022

Posted on February 16, 2022 by MissionIR

Lexaria’s animal study could be the first step to developing faster and better acting sildenafil oral formulations  The most prominent study for Lexaria in 2022 is HYPER-H21-4, investigating patented DehydraTECH(TM)-CBD for hypertension and heart disease Lexaria Bioscience (NASDAQ: LEXX), a … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), The Chopra Foundation Partner to Uncover Potential of Psychedelic Therapies in Mental Health

Posted on February 15, 2022 by MissionIR

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has entered a strategic partnership with The Chopra Foundation, a not-for-profit organization founded by Dr. Deepak Chopra, dedicated to improving health and well-being. Under the … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names BayMedica VP of Sales, Releases Q2 2022 Report

Posted on February 15, 2022 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has appointed Gerard (Jerry) P. Griffin III as vice president of sales and marketing at BayMedica, a wholly owned subsidiary of InMed. In his … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

Building Value for Companies and Investors: SRAX Inc. (NASDAQ: SRAX) Buys Back Stock, Pays Dividend

Posted on February 15, 2022 by MissionIR

SRAX has published a replay of its recent 2022 Sequire Metals & Mining Conference, including keynotes, and presentations from 70+ premier companies Per the $10 million share repurchase plan announced in Q3 2021, SRAX repurchased approximately $800,000 worth of stock … Continue reading →

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) in Unique Position to Offer Full Slate of Rare Cannabinoid Manufacturing Technologies

Posted on February 14, 2022 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM) understands the immense potential of rare cannabinoids and sees them as having applications as wide as cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”), variants of cannabinoids that make up most of the content in cannabis plants. Studies suggest … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Furthering Global Foothold as Leader in Plant-Based Wellness, Lifestyle Brands

Posted on February 14, 2022 by MissionIR

Flora Growth Corp. (NASDAQ: FLGC) is expanding its cannabis-derived brand presence in Latin American countries. Its Mind Naturals skincare brand, built with premium CBD and other high-quality ingredients, will be distributing a portfolio of 12 products through its agreement with … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Working on Turning Psychedelics-to-Therapeutics(TM) Vision into Reality

Posted on February 14, 2022 by MissionIR

Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is on a mission to revolutionize mental health care. The company has developed key relationships with a network of world-class partners … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Partners with Leading Global Security and Facility Services Company

Posted on February 14, 2022 by MissionIR

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced a strategic partnership with Allied Universal(R), a leading global security and facility services company with revenues of approximately $20 billion and more … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment